Both in Pharmaceuticals
CalciMedica vs GT Biopharma
Over the past year CALC returned −90.2% and GTBP returned −66.2%; their daily moves had a correlation of 0.02.
CALC −90.2% GTBP −66.2%Growth of $1, one year, split-adjusted
| Metric | CALC | GTBP |
|---|---|---|
| Price | $1.47 | $5.27 |
| Market cap | $10.0M | $9.5M |
| Today | +5.00% | +2.73% |
| 1 month | −4.5% | −14.4% |
| 6 months | −51.1% | −44.5% |
| Year to date | −95.5% | −73.2% |
| 1 year | −90.1% | −66.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $9.4M | $5.0M |
| Dividend yield | — | — |
| Volatility (60d) | 487.7% | 958.2% |
| Short % of float | 0.3% | 24.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).